Puma Biotechnology, Inc.PBYINASDAQ
Loading
Revenue PerformanceStable
Percentile Rank64
3Y CAGR+0.1%
5Y CAGR+0.3%
Studio
Year-over-Year Change

Total revenue from sales of goods and services

3Y CAGR
+0.1%/yr
vs -2.4%/yr prior
5Y CAGR
+0.3%/yr
Consistent
Acceleration
+2.4pp
Accelerating
Percentile
P64
Within normal range
vs 5Y Ago
1x
Modest growth
Streak
2 yr
Consecutive declineStable
PeriodValueYoY Change
TTM$228.42M-0.9%
2024$230.47M-2.2%
2023$235.64M+3.3%
2022$228.03M-9.9%
2021$253.16M+12.5%
2020$225.11M-17.3%
2019$272.26M+8.5%
2018$251.00M+806.1%
2017$27.70M-
2016$0.00-